Thank you , appreciate that, will look up.
Posts in category Value Pickr
Cineline India – Picture abhi baaki hai (01-04-2024)
Company participated in investor conference by Arihant capital, it will be live on Youtube in some. They shared the over the call
Krsnaa Diagnostics – what is the diagnosis? (01-04-2024)
LIC, Zomato, BOI, Infosys, Polycab, bunch of insurance companies, FMCG companies, Eicher Motors, Asian Paints, ICICI Pru are some of the dozens of big companies that have received tax demand notices recently. The government gave GST officers more time to issue demand notices for discrepancies in annual returns for 2018-19 and 2019-20 financial years, so we should expect a lot more notices until August 31, 2024.
Cineline India – Picture abhi baaki hai (01-04-2024)
can you share a source of the info please?
Journey and Portfolio of a goal-based NEEV investor (01-04-2024)
Date: 1st April 2024
Short update: I did nothing (mostly). Just wait and watch.
Actions in March 2024: Averaged in PHANTOM VFX.
Here’s my latest portfolio :
| Stock name | Weight % | Avg P/E | Profit / Loss % | IRR % | Action |
|---|---|---|---|---|---|
| MOST 100 ETF | 9.8 | 19.4 | 52% | 32% | |
| TIPS LIMITED | 8.4 | 20.6 | 140% | 73% | |
| TITAN | 8.2 | 47.2 | 107% | 29% | |
| TATA INVEST CORP | 7.7 | 27.5 | 234% | 162% | |
| BANK BEES ETF | 7.4 | 13.3 | 27% | 17% | |
| BAJAJ FINANCE | 7.3 | 22.5 | 42% | 14% | |
| COAL INDIA | 6.4 | 5.7 | 59% | 110% | |
| IRCTC | 6.1 | 26.9 | 159% | 55% | |
| PIDILITE | 4.9 | 57.2 | 57% | 19% | |
| DIXON | 4.7 | 43.9 | 184% | 96% | |
| INDIAMART | 4.5 | 51.7 | 7% | 35% | |
| NARAYANA HEALTH * | 4.3 | 24.0 | 41% | 57% | |
| ASIAN PAINTS | 4.3 | 47.1 | 7% | 8% | |
| VARUN BEVERAGES * | 4.0 | 46.5 | 90% | 61% | |
| TATA ELXSI | 3.9 | 34.0 | 79% | 57% | |
| IEX | 2.7 | 15.1 | 133% | 14% | |
| AMARA RAJA * | 2.1 | 16.0 | 12% | 24% | |
| WONDERLA * | 1.9 | 27.2 | 10% | 61% | |
| PHANTOM VFX * | 1.7 | 30.0 | 8% | 16% | Added more |
*(asterisk) signifies <1 yr holding period.
Here’s the return profile till 31st March 2024:
| Return till date | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since inception |
|---|---|---|---|---|---|---|---|
| MY PORTFOLIO | 0.6% | 6.5% | 19.4% | 57.1% | 19.5% | 22.2% | 21.6% |
| NIFTY 50 | 0.5% | 2.9% | 13.2% | 31.1% | 15.1% | 14.4% | 13.5% |
| NIFTY 500 | -0.4% | 4.7% | 16.6% | 41.7% | 18.2% | 16.5% | 15.2% |
Note: 1/3/6M is in absolutes while the 1/3/5Y/SI is annualized. Inception date is 10th Nov 2016.
100 invested in my portfolio:
Few other pointers for FY24:
- FY24 portfolio churn rate: 11% (expected to it to stay <10% – so kind of a miss)
- FY24 average portfolio beta: 0.96 (expected it to stay around 0.8)
- Trailing 12-month avg. portfolio PE: 30.3
Disclaimer: I am neither a financial nor a SEBI registered advisor. The content shared here is only for learning purposes. So please use your discretion to make any buy/sell decision and not use the above as a recommendation.
Investing Basics – Feel free to ask the most basic questions (01-04-2024)
Could someone explain why the NTPC N-7 bond is trading at 5.04 when the face value is 10?
Hindustan Foods (01-04-2024)
Point A )KNS Shoetech Private Limited Wholly owned subsidiary (w. e. f October 01, 2023):
Has entered into a Business Transfer Agreement (BTA) with SSIPL Retail Limited (“SSIPL”). This agreement entails the acquisition of manufacturing undertakings previously owned by SSIPL, located at Bangran and Bhagani in Himachal Pradesh as well as Kundli in Haryana. The total outlay for the transaction was more than Rs. 100 crores with the BTA amount of nearly Rs 77 crores. The facilities are catering to key customers like Puma, Reebok, Asics, Sketchers, etc. This acquisition marks a noteworthy expansion for KNS Shoetech Private Limited and Hindustan Foods Limited within the sports shoe manufacturing domain. This strategic move underscores the company’s commitment to enhancing their manufacturing capabilities and strengthening their presence in this sector.
Point B): The company will set the goal of Revenue of Rs 4000 Cr in FY26, the estimated revenue of FY 24 ~ 2600 Cr± with PAT margin ~2.70%. The important part of the last’s commentary, they have an ambitious target of the PAT margin ~ 3.5%. So interestingly to watch two events revenue and margin improvement on quarter on quarter. The company has a good liquidity position on cash.
So wait and watch the Q4 numbers and management commentary on business.
Krsnaa Diagnostics – what is the diagnosis? (01-04-2024)
20 crore tax notice received from the
income tax department. Can there be smoke without fire ?